Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 19Unknown 5Terminated 4Recruiting 4Active not recruiting 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3

Conditions

Neoplasm Metastasis 2Breast Neoplasms 2Polycystic Ovary Syndrome 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × Estradiol × Clear all
NCT05716516 2026-05-05

ESTHER

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

University of Washington

Phase 2 Recruiting
60 enrolled
Breast

Anatomic Stage III Breast Cancer AJCC v8

NCT05900895 2025-11-20

PHOEBE

Dartmouth-Hitchcock Medical Center

Phase 1 Recruiting
6 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03401047 2025-08-05

CRM009

University of Virginia

Phase EARLY_PHASE1 Recruiting
37 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡